Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, 11(81), p. e225-e225, 2020
DOI: 10.1136/annrheumdis-2020-218907
Links
Tools
Response to ‘Correspondence on ‘Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study’’ by Zheng et al
Journal article published in 2020 by
Dimitrios A. Pappas 
,
Gregory St John,
Carol J. Etzel,
Stefano Fiore,
Taylor Blachley,
Toshio Kimura,
Rajeshwari Punekar,
Kelechi Emeanuru,
Jeannie Choi,
Susan Boklage,
Joel M. Kremer
,
Gregory St John,
Carol J. Etzel,
Stefano Fiore,
Taylor Blachley,
Toshio Kimura,
Rajeshwari Punekar,
Kelechi Emeanuru,
Jeannie Choi,
Susan Boklage,
Joel M. Kremer
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 